Author

Nermeen Nabeel Abuelsoud

Observed names: Abuelsoud Nermeen Nabeel, Nermeen Abuelsoud, Nermeen Abuelsoud, Nermeen N. Abuelsoud, Nermeen Nabeel Abu-Elsoud

Institutions: Heliopolis University, Egyptian Russian University

Observed institutions: British University in Egypt, King Saud University, Heliopolis University, Egyptian Russian University

ORCID: 0000-0001-5732-2324

Observed ORCID: 0000-0001-5732-2324

OpenAlex ID: A5031139144

Pharmacy quality improvement project to enhance the medication management process in pediatric patients

2018 · Nermeen Abuelsoud · Irish Journal of Medical Science (1971 -) · 17

Evaluation of Electronic Information Resources for Questions Received by a College of Pharmacy Drug Information Center

2007 · Lamya S. Alnaim, Nermeen N. Abuelsoud · Drug Information Journal · 5

The role of brain natriuretic peptide biomarker in the detection of cardiotoxicity

2025 · Enas A. El-Shorbagy, Amira Abdelmonem Elsayed, et al. · ERU Research Journal · 4

Studying the association between some genetic polymorphisms and Doxorubicin-Induced Cardiotoxicity

2024 · Enas A. El-Shorbagy, Amira B. Kassem, et al. · International Journal of Clinical Medical Research · 3

The Association Between Azathioprine Genetic Polymorphisms, Clinical Efficacy and Adverse Drug Reactions Among Egyptian Patients with Autoimmune Diseases

2021 · Nermeen Abuelsoud, Hala Fayed, et al. · Pharmacogenomics and Personalized Medicine · 3

PDF

Improving medication safety through implementation of medication error reporting systems in different medical specialities

2018 · Nermeen Nabeel Abuelsoud · Journal of Pharmacy Practice and Research · 3

The impact of CBR3 (rs1056892) and ABCC1 (rs45511401) genetic polymorphisms on doxorubicin-induced cardiotoxicity and the potential role of brain natriuretic peptide as an early cardiac biomarker in breast cancer patients

2025 · Enas A. El-Shorbagy, Noha A. El-Bassiouny, et al. · Expert Opinion on Drug Metabolism & Toxicology · 2

Genetic polymorphisms effect on cyclophosphamide’s tolerability and clinical efficacy in Egyptian patients with lupus nephritis

2023 · Nermeen N. Abuelsoud, Engy M. EL Khateeb · Pharmacogenetics and Genomics · 2

The association between Covid-19 Infections, Severity, Complications and Vaccinations and Dyslipidemia in young age population - Clinical Pharmacy Approach

2023 · Nermeen Abuelsoud, Nouran Younis, et al. · Research Journal of Pharmacy and Technology · 2

EPHA5 and SOD2 genetic variants and their link to neurofilament light chain: early detection of taxane-induced neurotoxicity in Egyptian breast cancer patients

2025 · Amira B. Kassem, Amira Abdelmonem Ahmed, et al. · Future Journal of Pharmaceutical Sciences · 1

PDF

The effect of genetic polymorphisms, drug-disease and drug-drug interactions on hypertension control in Egyptian patients

2025 · Nermeen N. Abuelsoud, Fatma H. Abdelraouf · Research Journal of Pharmacy and Technology · 1

Studying the association between single nucleotide polymorphisms of metabolizing enzymes and the therapeutic serum levels of calcineurin inhibitors in Egyptian liver transplant patients

2024 · Nermeen N. Abuelsoud, Mohamed Bahaa, et al. · Future Journal of Pharmaceutical Sciences · 1

PDF

Untitled

2018 · Nermeen N. Abuelsoud · Asian Journal of Pharmaceutics · 1

PDF

Optimizing Warfarin use in Egyptian patients with Autoimmune Diseases – Genetic and Clinical Related Factors

2024 · Nermeen N. Abuelsoud, Lamees A. Samy · Research Journal of Pharmacy and Technology

Untitled

2022 · Nermeen Abuelsoud · Asian Journal of Pharmaceutics

PDF

Untitled

2022 · Nermeen Abuelsoud · Asian Journal of Pharmaceutics

PDF

Untitled

2018 · Nermeen Abuelsoud · Asian Journal of Pharmaceutics

PDF

Untitled

2017 · Nermeen Nabeel Abu-Elsoud · Asian Journal of Pharmaceutics

PDF

Comparison between the incidence of medication errors in four different hospitals in the Middle East

2015 · Abuelsoud Nermeen Nabeel · Clinical Pharmacology & Biopharmaceutics

Works count: 19

Citation count: 45

H-index: 3

I10-index: 1